Application 050504

Type
NDA
Sponsor
LILLY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MANDOLCEFAMANDOLE NAFATEINJECTABLE;INJECTIONEQ 500MG BASE/VIALNoNo
002MANDOLCEFAMANDOLE NAFATEINJECTABLE;INJECTIONEQ 1GM BASE/VIALNoNo
003MANDOLCEFAMANDOLE NAFATEINJECTABLE;INJECTIONEQ 2GM BASE/VIALNoNo
004MANDOLCEFAMANDOLE NAFATEINJECTABLE;INJECTIONEQ 10GM BASE/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050504-001MANDOLCEFAMANDOLE NAFATEEQ 500MG BASE/VIALINJECTABLE / INJECTIONApproved before 1982
N050504-002MANDOLCEFAMANDOLE NAFATEEQ 1GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982
N050504-003MANDOLCEFAMANDOLE NAFATEEQ 2GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982
N050504-004MANDOLCEFAMANDOLE NAFATEEQ 10GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N050504-001MANDOLEQ 500MG BASE/VIALINJECTABLE / INJECTIONApproved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N050504-002MANDOLEQ 1GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N050504-003MANDOLEQ 2GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N050504-004MANDOLEQ 10GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050504-001MANDOLEQ 500MG BASE/VIALINJECTABLE / INJECTIONApproved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N050504-002MANDOLEQ 1GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N050504-003MANDOLEQ 2GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N050504-004MANDOLEQ 10GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050504-001MANDOLEQ 500MG BASE/VIALINJECTABLE / INJECTIONApproved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050504-002MANDOLEQ 1GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050504-003MANDOLEQ 2GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050504-004MANDOLEQ 10GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050504-001MANDOLEQ 500MG BASE/VIALINJECTABLE / INJECTIONApproved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050504-002MANDOLEQ 1GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050504-003MANDOLEQ 2GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050504-004MANDOLEQ 10GM BASE/VIALINJECTABLE / INJECTIONApproved before 1982a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
7771SUPPL2003-03-10
7770SUPPL2002-07-18